Merck Animal Health Introduces SEQUIVITY™ Technology
Merck Animal Health, a global leader in vaccine development, is excited to deliver SEQUIVITY™ Technology. This innovative and highly advanced RNA Particle Technology is used to create flexible, safe and precise vaccine solutions to new and evolving disease challenges
12 June 2018
2 minute read
By: Vaccination is essential to disease prevention and has been key to protecting animal health. SEQUIVITY represents a technological advance within the company’s existing vaccine portfolio, with a platform that uses genetic sequences for specific antigens found in disease producing pathogens. This allows the creation of vaccines as needed in response to new or progressing diseases.
In an interview with The Pig Site, Joe Roder, DVM, technical services manager, Merck Animal Health, discusses the innovative platform technology which is allowing animal health specialists to create customisable vaccinations. Click here to watch the full interview.
Emily Houghton
Emily Houghton is a Zoology graduate from Cardiff University and was the editor of The Pig Site from October 2017 to May 2020. Emily has worked in livestock husbandry, and has written, conducted and assisted with research projects regarding the synthesis of welfare and productivity of free-range food species.
